• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Halozyme Therapeutics

Anonymous board for Halozyme Therapeutics
Replies
0
Views
289
anonymous
Replies
3
Views
2K
anonymous
Replies
5
Views
2K
anonymous
Replies
5
Views
4K
anonymous
Replies
1
Views
1K
anonymous
Replies
0
Views
1K
anonymous
Replies
1
Views
2K
anonymous
Replies
7
Views
11K
anonymous
Replies
0
Views
4K
anonymous
Replies
48
Views
25K
Anonymous
PEG
Replies
5
Views
5K
Anonymous
RIF
Replies
8
Views
4K
Anonymous
Replies
3
Views
4K
Anonymous
Replies
1
Views
4K
Anonymous
Replies
21
Views
9K
Anonymous
Replies
31
Views
10K
Anonymous
Replies
5
Views
4K
Anonymous
Replies
2
Views
4K
Anonymous
Replies
1
Views
4K
Anonymous